drugset
drugset / Trial / NCT05190133

Drug-drug Interaction Study Between UIC201601 and UIC201602

NCT05190133 ↗

Phase 1 Completed 40 enrolled Korea United Pharm. Inc.
RandomizedSequentialOpen-labelOther

Summary

An open-label, multiple-dosing, two-arms, one-sequence study to evaluate the safety and pharmacokinetics after co-administration of UIC201601 and UIC201602 in healthy male volunteers.

Timeline

Start
2016-05-28
Primary completion
2016-08-17
Completion
2016-08-17

Drugs

EvaluationDrugModalityDoseRoute
Subject UIC201601 Unknown — —
Subject UIC201602 Unknown — —

Indications

No indication recorded.